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1. Introduction
   Staphylococcus aureus (S. aureus) is the most common 
organism responsible for orthopaedic surgical site infections 
(SSIs) after elective joint arthroplasty. Patients who are 
carriers for methicillin resistant S. aureus (MRSA) have a 
higher likelihood of having invasive MRSA infections[1]. 
   Some reports have suggested that screening and 
decolonization of all patients having elective joint 
arthroplasty will decrease the incidence of postoperative 
infections[2]. They believe that a prescreening program 
(nasal swab using polymerase chain reaction-based testing), 
followed by an appropriate eradication using a 5- to 14-d 
course of nasal mucopirocin (2% nasal ointment) will lower 
the rate of SSIs[3]. 
   Although some have advocated screening and 
decolonization[3,4], it is unclear whether these efforts reduce 
SSIs[1]. In other words, while some institutions and surgeons 
have implemented universal screening and decolonization 
on their patients undergoing elective arthroplasty, others 
remain unconvinced about the efficacy of this process[5]. 
   The purpose of this article is to revise the literature with 
the aim of answering the following three questions: 1) Is 
screening and decolonization of MRSA effective in reducing 
the incidence of postoperative infection after elective joint 
arthroplasty? 2) Is decolonization cost-effective? 3) What is 
the durability of decolonization?
Objective: To review the literature with the aim of answering the following three questions: 1) 
Is screening and decolonization effective in reducing the rate of infection after elective joint 
arthroplasty? 2) Is screening and decolonization cost-effective? 3) What is the durability of 
decolonization? 
Methods: The search engines were MedLine (PubMed), Google Scholar and the Cochrane Library. 
The keywords used were: preoperative MRSA screening. Seven thousand nine hundred and 
forty eight articles were found until 30 September 2014 (seven thousand eight hundred and fifty 
in Google Scholar, ninety-seven in MedLine and one in the Cochrane Library). Of those, only 
eighteen were selected and reviewed because they were strictly focused on the question of this 
article. 
Results: The types of studies reported have a low level of evidence. Most of them are prospective 
case series, although some of them are systematic reviews of level III studies. There is a tendency 
toward fewer MRSA infections after elective joint arthroplasty. Decolonization has shown to 
be strongly cost-effective with 33% of postoperative arthroplasty patients tests positive for 
Staphylococcus aureus colonization at 3 to 30 months after surgery. 
Conclusions: There is a tendency toward fewer MRSA infections after total joint arthroplasty 
when screening and decolonization is used. Decolonization is strongly cost-effective procedure 
with 33% of patients tests positive for MRSA 3 to 30 months after surgery. Larger, randomized, 
controlled studies are needed to confirm the apparent efficacy of decolonization. 
Journal of Acute Disease (2014)218-220
Contents lists available at ScienceDirect
Journal of Acute Disease
journal homepage: www.jadweb.org
Article history:
Received 19 Dec 2014
Received in revised form  2014
Accepted 2014 
Available online 2014
219E. Carlos Rodriguez-Merchan/ Journal of Acute Disease (2014)218-220
2. Materials and methods
   A review has been performed on the role of screening 
and decolonization of MRSA in reducing the incidence of 
postoperative infection after elective joint arthroplasty. The 
keywords used were: preoperative MRSA screening. The 
search engines were MedLine (PubMed), Google Scholar 
and the Cochrane Library. Seven thousand eight hundred 
and forty eight articles were found until 30 September 2014 
(seven thousand eight hundred and fifty in Google Scholar, 
ninety-seven in MedLine and one in the Cochrane Library). 
Of those, only eighteen were selected and reviewed because 
they were strictly focused on the question of this article.
3. Results
   The types of studies reported have a low level of evidence 
(level III, level IV). Most of them are prospective case series 
(level IV), although some of them are systematic reviews 
of level III studies. A survey reported by Diekema et al. 
showed that only 60% of physicians reported preoperative 
screening for S. aureus[6]. The incidence of nasal carries of 
MRSA reported in the orthopaedic literature is very variable, 
ranging from 1.10% to 25.00% (Table 1)[3,7-14]. 
Table 1
Incidence of nasal carriers of MRSA and reduction of the rate of SSI 
in elective joint arthroplasty. 
Incidence of nasal carries of 
MRSA (%)
Reduction of the rate of  
SSI
Reference
6.00 NA [7]
0.23 From 0.30% to 0% [8]
1.10 NA [9]
1.45 From 1.45% to 1.28% [10]
4.40 From 0.97% to 0.14% [11]
6.60 NA [12]
0.49 From 0.49% to 0.24% [13]
18.00-25.00 NA [3]
4.60 From 4.6% to 0% [14]
NA: Nonavailable.
   Regarding the efficacy of decolonization, the orthopaedic 
literature has shown a tendency toward fewer MRSA 
infections after total joint arthroplasty (Table 1). In the study 
of Mehta et al. before implementation of screening and 
decolonization there was a prevalence density rate (MRSA-
positive cultures) of 1.23 per 1000 patient-days. After 
screening and decolonization, the rate was 0.83 per 1000 
patient-days[15]. 
   Two reports have shown that preoperative screening 
and decolonization of MRSA is strongly cost-effective 
(incremental cost-effectiveness ratio less than $6 000 per 
quality-adjusted life year) from the third-party payer 
perspective even when MRSA prevalence was as low as 1%, 
decolonization success was as low as 25%, and decolonization 
costs were as high as $300 per patient[16]. In most scenarios 
this strategy was economically dominant (i.e., less costly 
and more effective than no screening). Routine preoperative 
screening and decolonization of patients undergoing elective 
joint arthroplasty may under many circumstances save 
hospitals and third-party payers money while providing 
health benefits. Slover et al. conducted a Markov decision 
analysis to assess the cost savings associated with a 
preoperative MRSA screening and decolonization program 
on hip and knee arthroplasties[17]. They concluded that 
universal MRSA screening and decolonization for hip and 
knee arthroplasty patients needs to result in only a modest 
reduction in the SSI rate to be cost saving.
   Concerning the durability of decolonization, arthroplasty 
surgeons must be aware that a decolonization treatment 
does not guarantee that a patient will remain decolonized in 
the future[18]. In a study, 33% of postoperative arthroplasty 
patients tested positive for MRSA colonization at 3 to 30 
months after surgery despite preoperative decolonization[18].
4. Discussion
   The purpose of this article was to review the literature after 
2008 with the aim of answering the following the following 
three questions: 1) Is screening and decolonization of MRSA 
effective in reducing the rate of postoperative infection 
after elective joint arthroplasty? 2) Is decolonization cost-
effective? 3) What is the durability of decolonization?
   The quality of studies reported so far on the topic is poor 
(low level of evidence, level III, level IV). Most of them 
are prospective case series (level IV), although some are 
systematic reviews of level III studies[1-18].
   In a survey only 60% of physicians reported preoperative 
screening for S. aureus[6]. The incidence of nasal carries of 
MRSA in the orthopaedic literature is very variable, ranging 
from 1.10% to 25.00%[4,7-14]. 
   Regarding the efficacy of decolonization, a reduction 
of the incidence of postoperative SSI after elective joint 
arthroplasty has been found in the literature. The prevalence 
density rate (MRSA-positive cultures) of 1.23 per 1000 
patient-days before decolonization dropped to 0.83 per 1000 
patient-days after decolonization[14]. 
   Preoperative MRSA screening and decolonization is 
strongly cost-effective (incremental cost-effectiveness ratio 
less than $6 000 per quality-adjusted life year) from the 
third-party payer perspective even when MRSA prevalence 
was as low as 1%, decolonization success was as low as 25%, 
and decolonization costs were as high as $300 per patient[16]. 
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A Markov decision analysis showed that universal S. aureus 
screening and decolonization for hip and knee arthroplasty 
patients needs to result in only a modest reduction in the SSI 
rate to be cost saving.
   Concerning the durability of decolonization, arthroplasty 
surgeons must be aware that a decolonization treatment 
does not guarantee that a patient will remain decolonized in 
the future[18]. In a study, 33% of postoperative arthroplasty 
patients tested positive for MRSA colonization at 3 to 30 
months after surgery despite preoperative decolonization[18].
   In conclusion, the review of the literature found a tendency 
toward fewer MRSA SSIs after total joint arthroplasty 
when a screening and decolonization program was used. 
However, most of these studies were underpowered. Larger, 
randomized, controlled studies are needed to confirm 
the apparent efficacy of decolonization. Screening and 
decolonization is a cost-effective procedure. Regarding the 
durability of decolonization, one third of patients tested are 
positive for S. aureus at 3 to 30 months after surgery.
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